Loading...
Current guidelines for high-density lipoprotein cholesterol in therapy and future directions
Many studies have suggested that a significant risk factor for atherosclerotic cardiovascular disease (ASCVD) is low high-density lipoprotein cholesterol (HDL-C). Therefore, increasing HDL-C with therapeutic agents has been considered an attractive strategy. In the prestatin era, fibrates and niacin...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3986285/ https://ncbi.nlm.nih.gov/pubmed/24748800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S45648 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|